Older, less educated, male survivors less likely to have health promotion discussions
the ONA take:
Cancer survivors with diabetes and people less likely to engage in healthy behaviors were more likely to engage in health promotion discussions with their physicians, while males and older and less educated survivors were less likely to have these discussions, a recent study published online ahead of print in the Journal of Cancer Survivorship has shown.
For the study, researchers surveyed 874 lung cancer and colorectal cancer survivors about whether a physician discussed strategies to improve health, exercise, and diet habits in the previous year.
Results showed that 59% of participants reported that a physician discussed strategies to improve health and exercise, 44% reported diet discussions, and 24% reported no discussions.
Researchers found that survivors with lower education were less likely to report discussing all three topics, while survivors with diabetes were more likely.
Survivors 65 years and older were also less likely to report discussing strategies to improve health diet. On the other hand, male and colorectal cancer survivors were more likely to report discussing diet.
“Decreasing physician barriers and encouraging patients to discuss health promotion, especially in the context of clinical care for older survivors and those with low education, is essential for promoting the overall well-being of cancer survivors,” the authors conclude.
Cancer survivors with diabetes and people less likely to engage in healthy behaviors more likely to engage in health promotion discussions.
- Blood Test Predicts Stem Cell Transplant Success in Myelodysplastic Syndrome
- Immunotherapy and the Future of Prostate Cancer Treatment
- Elderly with NSCLC Can Tolerate Aggressive Radiation Therapy Treatments
- E-cigarettes and Replacement Nicotine Therapy Safer Than Tobacco Use
- Patients With Urologic Cancer Need Psycho-oncologic Support to Manage High Stress
- Lung Cancer Screening Rates Low Among Present and Former Smokers
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Patients Undergoing Multiple Systemic Therapies for Metastatic Prostate Cancer Expect a Cure
- FDA Grants Priority Review to Ceritinib for First-line Treatment of ALK+ NSCLC
- Overall Health Worse in African American Men Undergoing Active Surveillance For Prostate Cancer
- Clinical Benefit of Simtuzumab Inconsistent for Myelofibrosis
- Follow-up Rates in Active Surveillance for Prostate Cancer Higher in University-Based vs Safety-Net Hospitals
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|